Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1998
12/30/1998WO1998058677A1 Pharmaceutical formulations containing voriconazole
12/30/1998WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
12/30/1998WO1998058652A1 Stable aspirin ointment preparations
12/30/1998WO1998058651A1 Stable aspirin-containing preparations for external use
12/30/1998WO1998058629A2 Preparation of pharmaceutical compositions
12/30/1998WO1998044944A3 Stabilized human papillomavirus formulations
12/30/1998WO1998044936A3 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
12/30/1998WO1998043497A3 Oral compositions having enhanced mouthfeel
12/30/1998EP0887072A1 Use of sulfites and meta bisulfites, for the manufacturing of cosmetic or pharmaceutical compositions, principally for dermatologig, having an inhibitory effect on melanogenesis or skin whitening
12/30/1998EP0886680A1 Virus-like particle
12/30/1998EP0886654A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same
12/30/1998EP0886652A1 Pulmonary surfactant peptide solubilization process
12/30/1998EP0886649A1 Protein occlusion for delivery of small molecules
12/30/1998EP0886518A1 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
12/30/1998EP0886474A1 Caramels containing a sweetener
12/30/1998EP0886471A1 Methods and compositions for inducing oral tolerance in mammals
12/30/1998EP0801570A4 Formulations and methods for reducing skin irritation
12/30/1998EP0737201A4 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
12/30/1998EP0731785B1 Ceramide 3 derivatives based on monounsaturated fatty acids
12/30/1998EP0723432B1 Free flowing emulsion concentrate
12/30/1998EP0686142B1 Polyamine derivatives as radioprotective agents
12/30/1998EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
12/30/1998EP0553244B1 Targeted immunostimulation with bispecific reagents
12/30/1998EP0523184B1 Oil speil recovery method
12/30/1998CN1203527A Stable freeze-dried pharmaceutical formulation
12/30/1998CN1041436C Method for stabilizing rheumatism-traumatic medicinal liquor
12/30/1998CN1041419C Process for preparation of mitomycin C-dextran
12/30/1998CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells
12/30/1998CA2294348A1 Vaccines containing bordetella pertussis antigen
12/30/1998CA2264022A1 Stable aspirin-containing preparations for external use
12/29/1998US5854382 Bioresorbable compositions for implantable prostheses
12/29/1998US5854281 Preparation for percutaneous absorption
12/29/1998US5854270 Oral compositions containing ondansetron
12/29/1998US5854246 Topical ketoconazole emulsions
12/29/1998US5854226 Pharmaceutical composition
12/29/1998US5854225 Compounds derived from cyclodextrin
12/29/1998US5854223 S-DC28 as an antirestenosis agent after balloon injury
12/29/1998US5854208 Hepatoselective pharmaceutical actives
12/29/1998US5853758 Preparation of tablets of increased strength
12/29/1998US5853753 Liposomes, method of preparing the same and use thereof in the preparation of drugs
12/29/1998US5853752 Methods of preparing gas and gaseous precursor-filled microspheres
12/29/1998US5853751 Molecular transdermal transport system
12/29/1998US5853748 Pharmaceutical compositions
12/29/1998US5853736 Potentiation of immunogenic response
12/29/1998US5853732 Pharmaceutical compositions containing kukui nut oil
12/29/1998US5853723 Targeting of peg antibody conjugates to islet cells
12/29/1998US5853713 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
12/29/1998US5853616 Method for preparing low-concentration polyaluminosilicate microgels
12/29/1998CA2158583C Pharmaceutical composition in the form of a kit
12/29/1998CA2143413C Local drug delivery film, for periodontal treatment
12/29/1998CA1340297C Conjugation of polymer to colony stimulating factor-1
12/24/1998DE19726264A1 Preparation of homogeneous, stable, water-free formulation(s)
12/24/1998DE19725615A1 Zur topischen Applikation bestimmte Diclofenac-Lösung For topical application specific diclofenac solution
12/24/1998DE19724868A1 Stable cosmetic or pharmaceutical preparation, e.g. cream
12/24/1998DE19724696A1 Pharmazeutische Zubereitung mit drei Pelletarten Pharmaceutical composition with three pellet types
12/24/1998DE19724670A1 Inkorporation von pharmakologisch wirksamen Aminosäureanaloga in Proteine Incorporation of pharmacologically active amino acid analogues into proteins
12/23/1998WO1998058258A1 Formulation for immunological reaction systems
12/23/1998WO1998057662A2 Therapeutic systems
12/23/1998WO1998057646A1 Aqueous medicinal preparations for external use containing solubilized difluprednate
12/23/1998WO1998057630A1 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof
12/23/1998WO1998057625A2 Composition for controlling oxidation-reduction
12/23/1998WO1998057624A1 Diclofenac solution for topical application
12/23/1998WO1998041535A3 Activation of peptides
12/23/1998EP0885900A2 Increasing blood-brain barrier permeability with permeabilizer peptide derivatives of bradykinin
12/23/1998EP0885393A1 Graphitic nanotubes in luminescence assays
12/23/1998EP0885277A1 Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents
12/23/1998EP0885189A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
12/23/1998EP0885060A1 Solid and semi-solid hydrocarbon gels and uses thereof
12/23/1998EP0885016A1 Thermally stabilized contrast agent
12/23/1998EP0885015A2 Modified cytokines for therapeutic use
12/23/1998EP0885014A1 Pharmaceutical compositions containing buffered ortho ester polymers
12/23/1998EP0885010A1 Intercellular adhesion molecule powder formulation
12/23/1998EP0885002A2 Materials and methods for enhancing cellular internalization
12/23/1998EP0759741B1 Mucoadhesive emulsions containing cyclodextrin
12/23/1998EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
12/23/1998EP0719146B1 Novel method of progesterone delivery and effect thereof
12/23/1998EP0607222B1 Dendrimeric polychelants
12/23/1998EP0553294B1 The manufacture of compositions for the treatment of cell proliferation disorders
12/23/1998EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/23/1998EP0471792B1 Methods, reagents and test kits for determination of subpopulations of biological entities
12/23/1998EP0321464B1 Coatings based on polydextrose for aqueous film coating of pharmaceutical, food and confectionery products
12/23/1998CN1202903A Targeted cytotoxic anthracycline analogs
12/23/1998CN1202829A Method for preserving microoganisms
12/23/1998CN1202827A 1,2,4-benzotriazine oxides formulations
12/23/1998CN1202819A Composition for transdermal delivery
12/23/1998CN1041281C Polymer-bound taxol derivatives
12/23/1998CA2292608A1 Therapeutic systems for activation prodrugs
12/22/1998US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5851992 Treatment of growth hormone deficiency
12/22/1998US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor
12/22/1998US5851818 Condensed plasmid-liposome complex for transfection
12/22/1998US5851791 Ubiquitin conjugating enzyme (E2) fusion proteins
12/22/1998US5851670 In vivo-soluble composite particles comprising calcium phosphate
12/22/1998US5851546 Polymer composition for controlled release of active ingredients in response to pH, and a process of preparing the same
12/22/1998US5851543 Skin care preparation and method
12/22/1998US5851536 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
12/22/1998US5851527 Method for antibody targeting of therapeutic agents
12/22/1998US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998US5851517 Composition including a dispersion of polymer particles in a non-aqueous medium